Supporting the DAIDS Research Enterprise

Resources from the Division of AIDS (DAIDS) offices, including the Clinical Laboratory Operations Team (DCLOT), Office of Clinical Site Oversight (OCSO), and Office for Policy in Clinical Research Operations (OPCRO).

Announcements & Deadlines

Electronic Information Systems Policy Update

March 14, 2025

An update to the Electronic Information Systems (EIS) Policy was issued by DAIDS QA. Please see the memo for more information.

Clarification to the DAIDS AE Grading Table

February 28, 2025

The DAIDS Office for Policy in Clinical Research Operations (OPCRO) has made revisions to the DAIDS AE Grading Table.

Please see the memo and updated grading table for more information.

Expanded DAIDS Requirement for SOP Review and Approval

November 4, 2024

Beginning on December 1, 2024 and going forward, if a CRS makes substantial changes to one of the following four Site Required SOPs, the SOP should be submitted to the OCSO PO for review and approval before implementation. Please send the tracked changes version or include a summary of changes. Initial versions of these SOPs are reviewed during Site Activation.

1. Informed Consent Process
2. Enrolling Minors
3. Regulatory Inspection Readiness
4. CQMP

Please see the memo for additional details and refer to the SCORE Manual sections indicated. 

Common External Links

DAIDS Clinical Research Policies and Standard Procedures

DAIDS policies and procedures required for all human subjects research supported and/or sponsored by NIAID.

DAIDS Regulatory Support Center (RSC)

The DAIDS RSC provides support for all regulatory activities using the DAIDS Enterprise System (DAIDS-ES) within the NIAID Clinical Research Management System (NCRMS). 

DAIDS Organization Chart

Organization chart for the Division of AIDS and other divisions within the NIH National Institute of Allergy and Infectious Diseases (NIAID).


DAIDS Presentations and Trainings

If you are looking for Toolkits from the DART events in 2019 or 2022 please contact Rick Ferrer at ricardo.ferrer@nih.gov for more information.

DAIDS Co-Enrollment Prevention Requirements Webinar Slides

DAIDS Co-Enrollment Prevention Requirements Webinar Recording from September 28, 2021

Looking for more information? 

  • Examples of site Co-Enrollment Prevention SOPs are posted on the HANC Site Management Resources page under the Site SOP Templates section.
  • Find additional guidance, FAQs, and templates related to the DAIDS Co-Enrollment Prevention Requirements on the DAIDS SCORE Manual website under the Screening, Enrollment/Randomization, and Unblinding of Participants section. 

DAIDS EIS Policy Training Agenda

DAIDS EIS Policy Training Slides

DAIDS EIS Policy Training Recording (Session B) from June 11, 2021

DAIDS EIS Policy Training Recording (Session C) from June 29, 2021

Looking for more information? Find the DAIDS EIS Policy and appendices, including the EIS Checklist, implementation memo, and FAQs, on the NIAID website

  • More information about the 21 CRF Part 11 regulation can be found here.
  • EIS checklist submissions and queries related to the EIS checklist should be directed to DAIDSCRSSEISChecklist.sm@ppdi.com

DAIDS SCORE Manual Launch Webinar
February 9, 2021. Speaker: Gregg Roby.

DAIDS SCORE Manual Launch Slides

Looking for more information? Take a look at the answers to questions asked during the DAIDS SCORE Manual Launch sessions held on February 9, 2021 and February 11, 2021.

Additional updates related to the DAIDS SCORE Manual can be found in the Memos dropdown under OCSO Resources.

Remote Monitoring: Strategies for Site Preparedness and Planning
Presentation Slides
Medidata RSR FAQ
Presentation Q&A
October 4, 2023. Presenters: Steven Gordon, Bariatu Smith, Grace Roy, Kayode Koleoso, Doreen Campbell, Pia Lohse, Karen Reese.

Remote Source Document Verification (rSDV) FAQs
June 24, 2021.

Remote Monitoring: Visits Logistics for Sites
April 20, 2020. Presenters: Bariatu Smith, Karen Hufham, Manizhe Payton, Bola Adedeji, Karen Reese. Q&A session starts at 28:00.

Remote Monitoring: Visits Logistics for Sites Slides

Looking for more information? Take a look at the answers to questions asked during the DAIDS Remote Monitoring session held on April 20, 2020.

Additional updates related to Remote Monitoring and Source Document Verification can be found in the Memos dropdown under OCSO Resources.

DAIDS Monitoring Processes
October 7, 2019. Presented to the HANC Cross-Network Site Coordinators Working Group. Speakers: Bariatu Smith.

Protocol Deviations Working Group Presentation
June 19, 2019. Presented to the ACTG.

Protocol Signature Page Presentation
February 22, 2017.

DAIDS Clinical Laboratory Operations Team (DCLOT) Resources

Overview of the DAIDS Laboratory Audit Process

As clinical trial sponsor, DAIDS must oversee laboratory operations to ensure (with some level of confidence) that test results generated from all participating laboratories are accurate, reliable and auditable.

GCLP Standards and FAQs

This resource provides answers to the frequently asked questions (FAQs) regarding the DAIDS Guidelines for Good Clinical Laboratory Practice Standards deployment.


Office of Clinical Site Oversight (OCSO) Resources

View organization chart
Last modified February 17, 2021

Updates to DAIDS SCORE Manual: Appendix Source Documentation Requirements, Informed Consent of Participants, Site Visits
Summary of Changes
June 4, 2024

Minor Updates to DAIDS SCORE Manual
Summary of Changes
September 28, 2023

Minor Updates to DAIDS SCORE Manual: Investigator Responsibilities, Essential Documents, Essential Documents Recordkeeping Appendix, CRS Facility Requirements, Site Activation Process, Source Documentation Requirements Appendix and Record Retention
May 17, 2022

Flowchart Monitoring Update: Expansion of Medidata Remove Source Review (Medidata RSR) to Facilitate Remote Source Document Review
December 20, 2021

Minor Updates to DAIDS SCORE Manual: Documentation of Training and Use of Synchronized Clocks
November 8, 2021

New DAIDS Requirement for Clinical Research Sites: Co-Enrollment Prevention SOP
September 8, 2021

Minor Updates to DAIDS SCORE Manual: DAIDS Delegation of Duties Log Template
August 30, 2021

Expansion of PPD Remote Review of Pharmacy Source Documents for all DAIDS supported or sponsored clinical trials monitored by PPD
August 27, 2021

Minor Updates to DAIDS SCORE Manual: Quality Management, Pharmacy Requirements, Laboratory Requirements
June 28, 2021

Expansion of rSDV to All DAIDS Sponsored Clinical Trials
January 13, 2021

CQMP QA Summary Report Submission Requirements
October 23, 2020

Remote Monitoring Strategy-rSDV
July 23, 2020

Phased Approach to Resumption of On-Site Monitoring Visits
May 11, 2020

Suspension of On-Site Monitoring Visits Extended Through May 15, 2020 and CRS QA Summary Report due June 2020 Eliminated
April 6, 2020

Coronavirus Disease 2019 (COVID-19) Guidance: Suspension of On-Site Monitoring Visits Conducted by PPD at DAIDS Clinical Research Sites
March 19, 2020

New Pharmacy Operations Monitoring Assessment
December 10, 2019

DAIDS CQMP Policy: Submission Requirements
September 12, 2019

Revised Announced Work Order
May 2, 2019

Revised Monitoring Process
January 31, 2019

CQMP QA Summary Report and QM Activities
January 25, 2019

CQMP QA Summary Report and QM Activities
February 15, 2018

CQMP News Blast
February 2016December 20, 2021

DAIDS HIV/AIDS Network Clinical Research Site (CRS) Survey: SARS-CoV-2 Testing
This report is the results of the DAIDS HIV/AIDS Network Clinical Research Site (CRS) Survey: SARS-CoV-2 Testing conducted in April 2020.

Tutorial:  DAIDS QA Summary Report, New Excel Template
DAIDS developed an updated version of the CRS QA Summary Report Template in a Microsoft Excel format.  This tutorial will guide you through the different features included in the excel document.

Office for Policy in Clinical Research Operations (OPCRO) Resources